News

Aegle Therapeutics Appoints New Chairman Scott Braunstein, M.D.

Aegle Therapeutics Appoints New Chairman Scott Braunstein, M.D.

Aegle Therapeutics Welcomes New Chairman of the Board

Aegle Therapeutics, a rising name in the biopharmaceutical sector dedicated to developing innovative therapies for rare and severe skin diseases, has appointed Scott Braunstein, M.D. as the Chairman of the Board. This announcement marks a significant milestone for the company as it progresses its lead product candidate, AGLE-102.

About AGLE-102 and Its Potential

AGLE-102 is a cutting-edge therapy comprised of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs). Currently undergoing evaluation in a Phase 1/2a trial, AGLE-102 aims to treat recessive dystrophic epidermolysis bullosa (RDEB), a severe pediatric skin condition leading to painful blisters. Aegle aims to address a profound medical need through this innovative approach to treatment.

Impressive Background of Scott Braunstein, M.D.

Scott Braunstein, M.D., brings a wealth of experience to Aegle Therapeutics, contributing over 30 years of expertise in biotechnology and pharmaceuticals. Before this role, he was the President and Chief Executive Officer of Marinus Pharmaceuticals, which specialized in addressing rare forms of epilepsy, until its acquisition by Immedica Pharma AB.

His impressive career also includes serving as Senior Vice President and Chief Operating Officer at Pacira Pharmaceuticals, where he was instrumental in shaping strategies for specialty pharmaceuticals. Furthermore, Dr. Braunstein boasts significant experience from his twelve years at J.P. Morgan Asset Management as a Managing Director and Healthcare Analyst, diversifying his comprehensive understanding of the healthcare landscape.

Vision for Aegle Therapeutics

Dr. Braunstein expressed his enthusiasm upon joining Aegle, highlighting the company’s pivotal role in advancing therapies based on extracellular vesicles, which showcase immense potential for treating various dermatological conditions. He noted, "I look forward to working with Shelley and the management team to promote our mission of providing an innovative and effective biological solution for patients struggling with Epidermolysis Bullosa (EB)."

Leadership and Progress at Aegle Therapeutics

As Aegle continues to progress with AGLE-102, the leadership team will drive the development of this therapeutic platform further. Shelley Hartman, the CEO, expressed her confidence in Dr. Braunstein's insights and experience, seeing it as invaluable for guiding the team through future phases of their innovative research and clinical trials.

Broader Implications of AGLE-102

There is optimism surrounding the capability of AGLE-102 not just to treat RDEB but potentially other subtypes of epidermolysis bullosa and various dermatological issues characterized by inflammatory responses due to immune dysfunction. This reflects Aegle Therapeutics’ commitment to addressing a significant unmet medical need in dermatology.

Dr. Braunstein's Role and Contributions

In addition to Aegle Therapeutics, Dr. Braunstein is an operating partner at Aisling Capital and serves on multiple boards, influencing the direction of several innovative companies in the healthcare sector. His strategic oversight will aim to enhance Aegle’s position in the marketplace as they work towards achieving more clinical milestones.

About Aegle Therapeutics Corporation

Aegle Therapeutics Corporation is dedicated to developing novel extracellular vesicle therapies aimed at treating severe dermatological disorders. AGLE-102 has already made strides by demonstrating efficacy in preliminary studies related to severe burn treatments and is anticipated to pave the way for a broader treatment spectrum.

Frequently Asked Questions

What are the key responsibilities of Scott Braunstein as Chairman?

As Chairman, Scott Braunstein will guide Aegle's strategic direction, leveraging his industry insights to accelerate the development of AGLE-102 and other therapeutic initiatives.

What is AGLE-102 intended to treat?

AGLE-102 aims to treat recessive dystrophic epidermolysis bullosa, a rare and severe skin condition characterized by blister formation.

Why is extracellular vesicle therapy significant?

This therapy has the potential to revolutionize treatment approaches for various dermatological disorders by modulating inflammation and promoting healing.

How does Dr. Braunstein's experience benefit Aegle?

His extensive background in biotechnology and pharmaceuticals, coupled with his leadership roles in successful companies, equips Aegle with strategic insights and operational excellence.

What is the current status of AGLE-102?

AGLE-102 is currently undergoing a Phase 1/2a clinical trial for its efficacy and safety in treating RDEB.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 332

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 238

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 46

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 344

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ericsson Completes Major Buyback in November Burst

Updated Category News Views 22

Ericsson's Aggressive Share Repurchase Strategy Ericsson's share buyback spree might not be the first rodeo for seasoned investors out there, but their recent grab between November 9th and 13th surely made a few heads turn. The telecom giant snatched up a neat pile of 500,000 of its own Class B shares, maintaining the steady tick of their ambitious buyback program. It's...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
ELEGRP Makes Dyson Supersonic Global Voltage Ready

Updated Category News Views 15

Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Examining Consumer Trust: AI's Role in Holiday Shopping 2025

Updated Category News Views 206

Understanding Consumer Sentiments Towards AI in Holiday Shopping As the holiday shopping season approaches, a recent survey conducted by Sinch AB highlights a significant paradox affecting many brands this year. Although nearly half of consumers—about 48%—believe that artificial intelligence (AI) can streamline their shopping experience during peak times such as Black...

Continue Reading
Novonesis Concludes Successful Share Buyback with Strong Results

Updated Category News Views 201

Overview of Novonesis’ Share Buyback Program In the latest developments, Novonesis has successfully completed its share buyback initiative aimed at acquiring B shares, with a total commitment of up to EUR 100 million (approximately DKK 746 million) throughout 2025. This strategic move reflects the company's dedication to enhancing shareholder value and demonstrates its...

Continue Reading
Celebrating Women in Technology: Aragon Research Award Winners

Updated Category News Views 122

Celebrating Women in Technology Each year, Aragon Research proudly recognizes the groundbreaking achievements of women in the technology field. The 2025 Women in Tech Awards recognize individuals and innovations that not only advance their organizations but also inspire future generations of female leaders. This celebration serves to highlight the critical contributions...

Continue Reading
Caliber Introduces Innovative Opportunity Zone Fund Program

Updated Category News Views 86

Caliber (NASDAQ: CWD) launched its Qualified Opportunity Zone Fund Roll-Up program back in 2024, aiming to consolidate smaller funds into larger managed capital pools. This was a bold move for investors struggling with the complexities of Qualified Opportunity Funds (QOFs), and it certainly caught attention on the trading floor. Understanding QOFs: A Tax-Deferred...

Continue Reading
Intuitive Machines Achieves Record Q3 Growth and Contracts

Updated Category News Views 161

Intuitive Machines Celebrates Unprecedented Financial Growth Intuitive Machines, Inc. (NASDAQ: LUNR), a trailblazer in space exploration and services, proudly shares its impressive financial performance for the recent quarter. The company achieved remarkable revenue growth, securing notable contracts, and establishing a record cash balance. CEO Steve Altemus expressed his...

Continue Reading